Skip to main content

Series B Therapeutics Companies

Explore 186 therapeutics startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
186
Total Funding
$1.8B
Avg Funding
$71.0M
Cities
22

Export 186 Series B Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
$3.6M
raised

Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$45.2M
raised

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Portland, United States
$95.0M
raised

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Jersey City, United States
$17.0M
raised

Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Gladwyne, United States
$11.0M
raised

Xanadu Bio is a nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 186 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$60.0M
raised

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Natick, United States
$59.0M
raised

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$153.0M
raised

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

Aug 2025
Series B

Founder Contacts

41,000+ verified contacts

Nashville, United States
$30.0M
raised

Technology-driven infusion therapy company

Jun 2025
Series B

Founder Contacts

41,000+ verified contacts

Eindhoven, The Netherlands
$60.4M
raised

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 186 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Leiden, The Netherlands
$146.7M
raised

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$50.0M
raised

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Newark, United States
$29.4M
raised

Ace Vision Group develop laser-based therapeutic technologies to heal age-related eye dysfunction and restore the eye's natural performance.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Basel, Switzerland
$70.0M
raised

Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.

Apr 2025
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$65.0M
raised

Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 186 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Thousand Oaks, United States
$150.0M
raised

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$18.0M
raised

Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Syracuse, United States
$12.9M
raised

ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.

Jan 2025
Series B

Founder Contacts

41,000+ verified contacts

New Haven, United States
$75.0M
raised

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

Jan 2025
Series B

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$50.0M
raised

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.

Jan 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 186 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Durham, United States
$175.0M
raised

Tune Therapeutics is an epigenetic programming platform for the treatment of disease.

Jan 2025
Series B

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$161.0M
raised

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

Dec 2024
Series B

Founder Contacts

41,000+ verified contacts

Laval-ouest, Canada
$40.6M
raised

KisoJi Biotechnology is a biotechnology company focused on healthcare and life sciences for research and development industries.

Dec 2024
Series B

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$92.0M
raised

SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$104.5M
raised

Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 186 companies

Ready to Connect with Series B Therapeutics Startups?

Get verified founder emails, funding details, and company data for 186 series b therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked